Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01214863 · ClinicalTrials.gov registry record
AcrySof Toric Clinical Results
A clinical trial, sponsored by Alcon Research.
- Completed
- Registry status
- 144
- Enrollment target
NCT01214863: Completed study, sponsored by Alcon Research.
NCT01214863 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01214863 has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
This study is an evaluation of visual outcomes of subjects implanted with the AcrySof Toric Intraocular Lenses (IOLs) Models SN60T3, SN60T4, and SN60T5.
Interventions
- DEVICE T3
- DEVICE T4
- DEVICE T5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2007-08 |
What the finished NCT01214863 record still lists
NCT01214863 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which T3 is the first listed.
NCT01214863 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01214863 about?
NCT01214863 is a clinical study titled "AcrySof Toric Clinical Results". This study is an evaluation of visual outcomes of subjects implanted with the AcrySof Toric Intraocular Lenses (IOLs) Models SN60T3, SN60T4, and SN60T5.
What is the current status of trial NCT01214863?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2007-08.
What interventions are being tested in trial NCT01214863?
The interventions under investigation include: T3 (DEVICE), T4 (DEVICE), T5 (DEVICE).
Who is sponsoring clinical trial NCT01214863?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia